PFIZER INC (PFE) vs REGENERON PHARMACEUTICALS, INC. (REGN)
Side-by-side comparison from SEC filings: latest annual financials, insider activity and institutional ownership.
| Metric | PFE | REGN |
|---|---|---|
| Sector | Health Care | Health Care |
| Latest fiscal year | FY2025 | FY2025 |
| Revenue | $62.58B | $14.34B |
| Revenue growth (YoY) | ▼ 1.6% | ▲ 1.0% |
| Net income | $7.77B | $4.5B |
| Gross margin | 74.3% | — |
| Diluted EPS | $1.36 | $41.48 |
| Insider net (6 mo) | +109.6K sh • 2 sells • 3 buys | +2.3K sh • 7 sells • 0 buys |
| Institutional owners | 43 | 45 |
| Institutional value held | $61.91B | $38.9B |
| Next earnings (est.) | Nov 3, 2026 | Around Jan 11, 2027 |
Figures from each company's SEC filings (latest reported fiscal year; fiscal calendars may differ). Next-earnings dates are estimates from historical filing patterns.
About PFIZER INC (PFE)
Pfizer Inc. is a research-based, global biopharmaceutical company incorporated in Delaware in 1942 that applies science and global resources to discover, develop, manufacture, market, sell and distribute biopharmaceutical products worldwide, operating across… Read more →
About REGENERON PHARMACEUTICALS, INC. (REGN)
Regeneron Pharmaceuticals, Inc. is a fully integrated biotechnology company that invents, develops, manufactures, and commercializes medicines for people with serious diseases, including eye diseases, allergic and inflammatory diseases, cancer, cardiovascular… Read more →
Source: SEC EDGAR.